Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Federal Trade Commission
Argus Health
US Army
Baxter
Cipla
Moodys
UBS

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,147,461

« Back to Dashboard

Summary for Patent: 8,147,461
Title:Fluid dispensing device
Abstract: A fluid dispensing device for dispensing a fluid product having a dispensing outlet from which the fluid product is dispensable, a supply of the fluid product, a dispensing member mounted for movement in a dispensing direction along an axis X-X from a first position to a second position which causes a dose of the fluid product in the supply to be dispensed from the dispensing outlet, and a finger-operable actuator member mounted for movement in an actuating direction which is generally transverse to the axis.
Inventor(s): Bonney; Stanley George (Ware, GB), Connell; Hugh Alexander (Evesham, GB), Davies; Michael Birsha (Ware, GB), Godfrey; James William (Ware, GB), Hedley; Mark Graham (Ware, GB), Tansley; Robert William (Bidford on Avon, GB)
Assignee: Glaxo Group Limited (Greenford, Middlesex, GB)
Application Number:10/598,464
Patent Claim Types:
see list of patent claims
Device; Use;

Drugs Protected by US Patent 8,147,461

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Glaxosmithkline Cons FLONASE SENSIMIST ALLERGY RELIEF fluticasone furoate SPRAY, METERED;NASAL 022051-002 Aug 2, 2016 OTC Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,147,461

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0405477.1Mar 11, 2004
PCT Information
PCT FiledMarch 10, 2005PCT Application Number:PCT/GB2005/000944
PCT Publication Date:September 22, 2005PCT Publication Number: WO2005/087615

Non-Orange Book US Patents Family Members for Patent 8,147,461

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,752,543 Fluid dispensing device ➤ Try a Free Trial
9,320,862 Fluid dispensing device ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,147,461

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1901958 ➤ Try a Free Trial
China 1930054 ➤ Try a Free Trial
European Patent Office 1723052 ➤ Try a Free Trial
Spain 2388434 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKesson
Johnson and Johnson
Healthtrust
Fuji
US Army
US Department of Justice
Cerilliant
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.